HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.


Contact your representative.

Get answers to your questions. Talk to a representative about HYQVIA.

Your local Takeda representative is ready to support you and help answer your questions about HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. Simply enter your ZIP code below to get in touch with your dedicated TAKEDA representative, or call 1-877-825-3327 to speak with customer service.

*Indicates a required field.

By providing your information, you certify that you are a US healthcare professional and you are opting to receive information about Primary Immunodeficiency (PI) and PI products and other information from Takeda. You hereby give consent to Takeda, its affiliates and their agents and representatives to send communications and information to you via the contact information you have provided above. Takeda will not sell or transfer my name or contact information to any third party for their marketing use. This consent will be in effect until such time as you opt out of communications from Takeda.

If you ever decide that you do not wish to receive this information from us, contact us at: Consumer Relations, Takeda Pharmaceutical Company Limited 300 Shire Way, Lexington, MA 02421 or at 1-800-423-2090. We encourage you to read our privacy policy.